FDA approves Colorado plan to import lower-cost drugs from Canada

The U.S. Food and Drug Administration issued a letter confirming that Colorado may move forward with a pilot program to bring prescription medicines from Canada.

The proposal aims to lower drug costs for Colorado residents by allowing the state to purchase approved medications at Canadian prices, which are typically less than U.S. prices.

The FDA did not specify a timeline or detailed procedures for how the imports will be sourced, inspected, or distributed, leaving the implementation steps to state officials.

Stakeholders note that while the approval signals regulatory openness to cross-border drug sourcing, practical challenges such as supply chain logistics and safety oversight remain to be addressed.